IGF1R and breast carcinoma: The effects of suppressing ATR with siRNA were further tested in the ZR-75-1 ductal breast carcinoma cell line, which was previously shown to be resistant to IGF-1R inhibition (IC50 2μM for BMS-754807) [32].